Trevi Therapeutics   Report issue

For profit Phase 1 Phase 3
Founded: Sandy Hook CT United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2013
NCT02373215
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Trevi Therapeutics | Trevi Therapeutics, Inc | Trevi Therapeutics, Inc.